A user shared a clinical study discussing the link between GLP-1 receptor agonists (like Liraglutide) and increased risks of depression and anxiety, particularly in those with prior psychiatric issues. They personally experienced a persistent ‘underlying depression’ and a lack of motivation to socialize or exercise, which intensified following dose increases.